Skip to main content
Caplight Logo









Aanika Biosciences

Aanika Biosciences

Private
Brooklyn, New YorkFinTechhttps://www.aanikabio.com/

Last Round

Grant

May 31, 2023

Total Funding Raised

$15.9M

Company Overview

Aanika Biosciences is a biotechnology company that provides supply chain traceability and risk management solutions using edible, microbial tags.

Sector

FinTech

Verticals

InsurTech, Supply Chain Tracking, Biotechnology, Lending & Credit

Business Model

B2B

Customer Profile

Marketplace Commission, Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

microbial tagsfood traceabilityagricultural insurancemanaging general agentMGAinsurtechagritechsupply chain risk managementbiological barcodeDNA taggingsynthetic biologyfoodtechprovenance trackingfood recall insurancespray drift coverage

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aanika Biosciences Comparables

Compare Aanika Biosciences with similar companies based on industry and business-model similarity.

Aanika Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Natural Trace
80%
TruTag Technologies
76%
BNB Plus Corp.
68%

Aanika Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 31, 2023
Series ANov 30, 2021
SeedNov 20, 2019
Pre SeedFeb 6, 2019

Key People

Founding team and executive leadership

Jamie Richards

Chief Technology Officer

Executive Team

Aanika Biosciences Investors

Notable investors and investment history

Aanika Biosciences investors
InvestorRounds
New York City Economic Development CorporationGrant
ADIT VenturesSeries A
Draper AssociatesSeries A, Pre Seed, Seed
Adit VenturesSeries A
RebelBioSeed
SOSVSeries A, Seed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 31, 2023

    $800K grant from New York City Economic Development Corporation.

Aanika Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aanika Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aanika Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersBrooklyn, New York
Employee Range11
Year Founded2018
Last FundingMay 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?